Characteristics | Non-recurrent (n = 10) | Recurrent (n = 10) | P-value |
---|---|---|---|
Median age (range) | 67.5 (49–75) | 71.5 (67–89) | 0.069 |
Gender (male/female) | 7/3 | 7/3 | 1.000 |
Smoking history (+/−) | 7/3 | 6/4 | 1.000 |
Pathological stage (I/II) | 10/0 | 5/5 | 0.033 |
Median tumor size (mm) (range) | 23.5 (9–29) | 24 (9–37) | 0.649 |
Adenocarcinoma subtype | Â | Â | 0.293 |
 Lepidic | 2 | 0 |  |
 Papillary | 5 | 7 |  |
 Acinar | 1 | 2 |  |
 Solid | 2 | 1 |  |
Lymph node metastasis (+/−) | 0/10 | 5/5 | 0.033 |
Pleural invasion (+/−) | 2/8 | 5/5 | 0.350 |
Lymphatic vessel invasion (+/−) | 1/9 | 6/4 | 0.057 |
Blood vessel invasion (+/−) | 2/8 | 9/1 | 0.005 |
Micropapillary component (+/−) | 5/5 | 8/2 | 0.350 |
Spread through air space (+/−) | 2/8 | 4/6 | 0.628 |
Driver gene mutation | |||
 EGFR (+/−) | 2/8 | 6/4 | 0.170 |
 ALK (+/−) | 0/8 | 0/7 | – |
Surgical procedure | Â | Â | 1.000 |
 Lobectomy | 10 | 9 |  |
 Wedge resection | 0 | 1 |  |
Adjuvant chemotherapy | Â | Â | 1.000 |
 Indication (Stage IA3-IIB) | 8 | 9 |  |
 Received | 4 | 4 |  |
Recurrent style |  |  | – |
 Locoregional | – | 3 |  |
 Distant | – | 8 |  |